{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.117.1.7.1.211","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.117.1.7.1.211/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.211","version":"eCQM Update 2020-05-07","name":"InjectableFactorXaInhibitorForVTEProphylaxis","title":"Injectable Factor Xa Inhibitor for VTE Prophylaxis","status":"active","date":"2017-07-26","description":"(Clinical Focus: This value set contains concepts that represent codes which identify injectable factor Xa inhibitors, which are used for venous thromboembolism (VTE) prophylaxis.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a select injectable factor Xa inhibitor as prophylaxis for VTE. ),(Inclusion Criteria: Includes only relevant concepts associated with injectable factor Xa inhibitor medications. These are RxNorm codes.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2020-01","concept":[{"code":"861356","display":"0.8 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe"},{"code":"861360","display":"0.5 ML Fondaparinux sodium 5 MG/ML Prefilled Syringe"},{"code":"861363","display":"0.4 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe"},{"code":"861365","display":"0.6 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe"}]}]}}